Statins utilisation pattern: a retrospective evaluation in a tertiary care hospital in Thailand

Author:

Chaiyakunapruk Nathorn12345,Asuphol Olarik2,Dhippayom Teerapon25,Poowaruttanawiwit Prayuth12,Jeanpeerapong Napawan6

Affiliation:

1. Center of Pharmaceutical Outcomes Research (CPOR), University of Wisconsin-Madison, WI, USA

2. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Wisconsin-Madison, WI, USA

3. School of Population Health, University of Queensland, Brisbane, Australia

4. School of Pharmacy, University of Wisconsin-Madison, WI, USA

5. Pharmaceutical Care Research Unit, Naresuan University, USA

6. Buddhachinnaraj Hospital, Phitsanulok, Thailand

Abstract

Abstract Objectives To determine statin usage pattern and evaluate whether new generation statins are actually needed by the patients receiving them. Methods This retrospective cohort included patients receiving first-time statins at a tertiary care hospital in Thailand. Using electronic medical records from 2005, its indication was determined based on history of coronary heart disease (CHD) and CHD-risk equivalents. The lipid profiles tested within 30 days prior to the first date of statins prescription were analysed. Each patient was assessed as to whether statin was needed based on low-density lipoprotein cholesterol (LDL-C) reduction capacity and lipid goals. Results A total of 2479 first-time statin users was included. Ninety percent of the users received simvastatin, while 8% and 2% received atorvastatin and pravastatin respectively. More than half (58.0%) used statins for primary prevention, although all usage of atorvastatin was considered not needed. Considering the use of statin for secondary prevention to achieve the LDL-C goal of <130 mg/dl (3.37 mmol/l), more than 80% of atorvastatin users could be switched to simvastatin. Only 8% of simvastatin usage would not be able to achieve this target. When the LDL-C goal was <70 mg/dl (1.81 mmol/l), 40.2% simvastatin users was considered appropriate, while 58.6% needed atorvastatin to be prescribed. Conclusion A substantial proportion of patients did not need statins therapy, particularly for primary prevention. In addition, atorvastatin use is mostly not needed except in patients requiring statins for secondary prevention to achieve the LDL-C goal of <70 mg/dl (1.81 mmol/l). The findings should prompt hospital policy makers to develop measures to ensure the proper use of statins in their clinical settings.

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmaceutical Science,Pharmacy

Reference31 articles.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Evaluation of statin utilisation in tertiary care teaching hospital: An observational prospective study, YSR Kadapa;Journal of Pharmacovigilance and Drug Research;2023-06-01

2. Pharmaceutical Care in Asia;The Pharmacist Guide to Implementing Pharmaceutical Care;2018-09-18

3. Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation;Journal of Thrombosis and Thrombolysis;2017-11-27

4. Pharmacy Practice in Thailand;Pharmacy Practice in Developing Countries;2016

5. Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency;Therapeutics and Clinical Risk Management;2015-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3